Results for &quot;&quot;Cefiderocol&quot;&quot;[mesh_terms]

Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro.

Diana Celedonio, Mylene Vaillancourt, Janet S Lee, Anna Clara M Galdino, Peter Jorth, Yohei Doi, Kara Huse

Nature microbiology 2024;9(3):631-646

Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials.

Patrice Nordmann, Ryan K Shields, Miki Takemura, Yoshinori Yamano, Yuko Matsunaga, Roger Echols, Yohei Doi

Microbial drug resistance (Larchmont, N.Y.) 2022;28(4):398-407

Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study.

Simon Portsmouth, Anju Menon, Roger Echols, Yuko Matsunaga, Eric P Skaar

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2022;41(3):467-476

Treatment of carbapenem-resistant infections: a case for cefiderocol.

Patricia J Simner, Yohei Doi, Rafael Canton

Expert review of anti-infective therapy 2022;20(8):1077-1094

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting.

B Sádaba Díaz de Rada, J R Azanza Perea

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2022;35 Suppl 2(Suppl 2):28-34

Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpoint.

Laurent Dortet, Anaïs Potron, Katy Jeannot, Aurélien Dinh, Clara Duran, Frédérique Bouchand, Julien Massol, François Jehl

Journal of global antimicrobial resistance 2024;38():140-145

Risk factors and treatment advances for carbapenem-resistant Enterobacteriaceae infections in the urinary tract.

Xuming Zhang, Shouyu Miao, Chaoyue Ji, Weiguo Hu

Frontiers in cellular and infection microbiology 2026;15():1724851

Antibacterial spectrum of cefiderocol.

R Cantón, P Ruiz-Garbajosa, J A Castillo-Polo, D Gijón Cordero

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2022;35 Suppl 2(Suppl 2):20-27

Cefiderocol: a novel siderophore cephalosporin.

Justin J Choi, Matthew W McCarthy

Expert opinion on investigational drugs 2018;27(2):193-197

Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters.

Takayuki Katsube, Shiro Miyazaki, Yukitoshi Narukawa, Martha Hernandez-Illas, Toshihiro Wajima

European journal of clinical pharmacology 2018;74(7):931-938

Complete Genome Sequence of a Strain Carrying Novel Variant , Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023.

Cristina Costa, Paolo Gaibani, Stefano Amadesi, Gabriele Bianco, Benedetta Secci, Teresa Fasciana, Matteo Boattini

Pathogens (Basel, Switzerland) 2025;13(6):

Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae.

Vincenzo Scaglione, Gian Masria Rossolini, Lorenzo Paci, Marco Coppi, Annamaria Cattelan, Elisa Franchin, Ignazio Castagliuolo, Maria Mazzitelli

The Journal of antimicrobial chemotherapy 2025;80(9):2442-2446